Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|October 13, 2021
Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to ChemoradiotherapyMelanie Spitzner, Georg Emons, Karl Burkhard Schütz, et al.
Cancers|March 10, 2022
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to ChemoradiotherapyHannah Flebbe, Melanie Spitzner, Philipp Enno Marquet, et al.
Clinical & Experimental Metastasis|January 26, 2019
Hepatic arterial infusion of irinotecan and EmboCept® S results in high tumor concentration of SN-38 in a rat model of colorectal liver metastasesAnne Kauffels, Marie Kitzmüller, Andrea Gruber, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
A gene expression signature for chemoradiosensitivity of colorectal cancer cellsMelanie Spitzner, Georg Emons, Frank Kramer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 13, 2013
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7gJunius Salendo, Melanie Spitzner, Frank Kramer, et al.
BMC Cancer|September 7, 2019
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancerLena-Christin Conradi, Melanie Spitzner, Anna-Lena Metzger, et al.
International Journal of Cancer|May 18, 2010
A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targetsMarian Grade, Amanda B Hummon, Jordi Camps, et al.
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
United European Gastroenterology Journal|September 16, 2025
Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal CancerJonas Buchloh, Melanie Spitzner, Hauke Zimmermann, et al.
Pageof 3